Tag Archives: KPTI
Monday’s Midday Stock Update: Virnetx Holding (VHC), Marathon Petroleum (MPC), Goodrich Petroleum (GDP), Karyopharm Therapeutics (KPTI), Arena Pharma (ARNA)
So far Monday, November 2, NASDAQ is down -4.32% and the S&P is down -1.05%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Virnetx Holding (VHC – Research Report), Marathon Petroleum (MPC –
Analysts Offer Insights on Healthcare Companies: Karyopharm Therapeutics (NASDAQ: KPTI) and Acasti Pharma (NASDAQ: ACST)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Karyopharm Therapeutics (KPTI – Research Report) and Acasti Pharma (ACST – Research Report). Karyopharm Therapeutics (KPTI) Barclays analyst Peter Lawson maintained a Buy
Sunday’s Highlights at Noon: Amarin (AMRN), Virnetx Holding (VHC), Sina (SINA), Karyopharm Therapeutics (KPTI), Splunk (SPLK)
So far Sunday, May 24, NASDAQ is up 1.15% and the S&P is up 0.89%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Amarin (AMRN – Research Report), Virnetx Holding (VHC – Research
H.C. Wainwright Sticks to Their Buy Rating for Karyopharm Therapeutics (KPTI)
H.C. Wainwright analyst Edward White reiterated a Buy rating on Karyopharm Therapeutics (KPTI – Research Report) on May 20 and set a price target of $40.00. The company’s shares closed last Friday at $20.65. According to TipRanks.com, White is a
Wednesday’s Highlights at Noon: Goodrich Petroleum (GDP), SunPower (SPWR), Chesapeake Energy (CHK), Karyopharm Therapeutics (KPTI), McKesson (MCK)
So far Wednesday, May 20, NASDAQ is up 2.49% and the S&P is up 1%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Goodrich Petroleum (GDP – Research Report), SunPower (SPWR – Research
Analysts Have Conflicting Sentiments on These Healthcare Companies: Karyopharm Therapeutics (NASDAQ: KPTI), aTyr Pharma (NASDAQ: LIFE) and Arvinas Holding Company (NASDAQ: ARVN)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Karyopharm Therapeutics (KPTI – Research Report), aTyr Pharma (LIFE – Research Report) and Arvinas Holding Company (ARVN – Research Report). Karyopharm Therapeutics (KPTI)
